{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Rhinitis%2C+Allergic%2C+Perennial", "query": { "condition": "Rhinitis, Allergic, Perennial" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 71, "total_pages": 8, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Rhinitis%2C+Allergic%2C+Perennial&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-06-11T00:31:20.306Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00659750", "title": "To Assess the Safety and Efficacy of Ciclesonide Applied as a Nasal Spray in the Treatment of Perennial Allergic Rhinitis (BY9010/M1-402)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Rhinitis, Allergic, Perennial" ], "interventions": [ { "name": "Ciclesonide", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 418, "start_date": "2003-12", "completion_date": "2005-04", "has_results": false, "last_update_posted_date": "2016-12-02", "last_synced_at": "2026-06-11T00:31:20.306Z", "location_count": 23, "location_summary": "Encinitas, California • Long Beach, California • Los Angeles, California + 19 more", "locations": [ { "city": "Encinitas", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Mission Viejo", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00659750" }, { "nct_id": "NCT01018862", "title": "A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Perennial Allergic Rhinitis" ], "interventions": [ { "name": "Azelastine hydrochloride nasal spray 0.15%", "type": "DRUG" }, { "name": "Azelastine hydrochloride nasal spray 0.10%", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Meda Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "12 Years", "sex": "ALL", "summary": "6 Years to 12 Years" }, "enrollment_count": 489, "start_date": "2009-11", "completion_date": "2011-04", "has_results": true, "last_update_posted_date": "2012-06-11", "last_synced_at": "2026-06-11T00:31:20.306Z", "location_count": 39, "location_summary": "Costa Mesa, California • Long Beach, California • Mission Viejo, California + 34 more", "locations": [ { "city": "Costa Mesa", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Mission Viejo", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "Sacramento", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01018862" }, { "nct_id": "NCT02696850", "title": "The Impact Of The Addition Of Budesonide To Low-Pressure, High-Volume Saline Sinus Irrigation For Chronic Rhinosinusitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Rhinosinusitis", "Chronic Eosinophilic Rhinosinusitis", "Allergic Rhinosinusitis" ], "interventions": [ { "name": "Budesonide", "type": "DRUG" }, { "name": "Saline alone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Washington University School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 80, "start_date": "2016-01-01", "completion_date": "2017-04-13", "has_results": true, "last_update_posted_date": "2019-09-03", "last_synced_at": "2026-06-11T00:31:20.306Z", "location_count": 1, "location_summary": "St Louis, Missouri", "locations": [ { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT02696850" }, { "nct_id": "NCT00720382", "title": "A Study to Evaluate the Safety and Tolerability of a Nasal Spray to Treat Perennial Allergic Rhinitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Perennial Allergic Rhinitis" ], "interventions": [ { "name": "0.15% azelastine hydrochloride", "type": "DRUG" }, { "name": "Mometasone furoate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Meda Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 703, "start_date": "2007-03", "completion_date": "2008-07", "has_results": true, "last_update_posted_date": "2015-05-21", "last_synced_at": "2026-06-11T00:31:20.306Z", "location_count": 59, "location_summary": "Oxford, Alabama • Fountain Valley, California • Huntington Beach, California + 50 more", "locations": [ { "city": "Oxford", "state": "Alabama" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00720382" }, { "nct_id": "NCT00712920", "title": "A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Perennial Allergies", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Perennial Allergic Rhinitis" ], "interventions": [ { "name": "0.15% azelastine hydrochloride", "type": "DRUG" }, { "name": "0.1% azelastine hydrochloride", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Meda Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 581, "start_date": "2007-01", "completion_date": null, "has_results": true, "last_update_posted_date": "2011-06-08", "last_synced_at": "2026-06-11T00:31:20.306Z", "location_count": 43, "location_summary": "Huntington Beach, California • Long Beach, California • Los Angeles, California + 35 more", "locations": [ { "city": "Huntington Beach", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Mission Viejo", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00712920" }, { "nct_id": "NCT00793858", "title": "A Pilot Investigation of Ciclesonide When Administered as a Hypotonic Versus an Isotonic Formulation of Ciclesonide Nasal Spray", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Allergic Rhinitis" ], "interventions": [ { "name": "placebo, isotonic ciclesonide, hypotonic ciclesonide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Chicago", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 0, "start_date": "2009-02", "completion_date": null, "has_results": false, "last_update_posted_date": "2013-06-07", "last_synced_at": "2026-06-11T00:31:20.306Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00793858" }, { "nct_id": "NCT00789555", "title": "Safety of PATANASE Nasal Spray in Patients With Perennial Allergic Rhinitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Perennial Allergic Rhinitis" ], "interventions": [ { "name": "Olopatadine hydrochloride 0.6% nasal spray (PATANASE)", "type": "DRUG" }, { "name": "Olopatadine nasal spray vehicle, pH 3.7", "type": "OTHER" }, { "name": "Olopatadine nasal spray vehicle, pH 7.0", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Alcon Research", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 1260, "start_date": "2008-11", "completion_date": "2011-01", "has_results": true, "last_update_posted_date": "2018-02-08", "last_synced_at": "2026-06-11T00:31:20.306Z", "location_count": 1, "location_summary": "Fort Worth, Texas", "locations": [ { "city": "Fort Worth", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00789555" }, { "nct_id": "NCT03360071", "title": "A Novel Biologic Therapy for Perennial Allergic Rhinitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Allergic Rhinitis" ], "interventions": [ { "name": "Allergen Immunotherapy Extract", "type": "DRUG" }, { "name": "Allergen Immunotherapy Control", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Johns Hopkins University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 31, "start_date": "2016-12-19", "completion_date": "2018-11-01", "has_results": true, "last_update_posted_date": "2019-09-04", "last_synced_at": "2026-06-11T00:31:20.306Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT03360071" }, { "nct_id": "NCT00659048", "title": "Investigation of Potential Additive Inhibitory Effects on HPA-Axis of Ciclesonide Nasal Spray When Administered Concomitantly With Orally Inhaled Beclomethasone Dipropionate (HFA-BDP) in Patients With Perennial Allergic Rhinitis (PAR) (BY9010/M1-408)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Rhinitis, Allergic, Perennial" ], "interventions": [ { "name": "Ciclesonide", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 106, "start_date": "2004-12", "completion_date": "2005-12", "has_results": false, "last_update_posted_date": "2016-12-01", "last_synced_at": "2026-06-11T00:31:20.306Z", "location_count": 1, "location_summary": "San Antonio, Texas", "locations": [ { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00659048" }, { "nct_id": "NCT00289198", "title": "Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Rhinitis, Allergic, Perennial" ], "interventions": [ { "name": "FF", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 301, "start_date": "2006-02-07", "completion_date": "2006-07-04", "has_results": true, "last_update_posted_date": "2018-04-13", "last_synced_at": "2026-06-11T00:31:20.306Z", "location_count": 8, "location_summary": "San Diego, California • Baltimore, Maryland • Wheaton, Maryland + 5 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Wheaton", "state": "Maryland" }, { "city": "North Dartmouth", "state": "Massachusetts" }, { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT00289198" } ] }